secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001493152-23-018373
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics receives Nasdaq delisting notice; plans appeal and reverse stock split
--------------------------------------------------------------------------------

- Nasdaq notified BBLG on May 18, 2023 that its common stock and warrants are subject to delisting for failing to maintain $1.00 bid price.
- Company will request a hearing before Nasdaq Hearings Panel to appeal, which stays delisting pending decision.
- Stockholders approved a reverse stock split at ratio between 1:20 and 1:50 on May 1, 2023 to help regain bid price compliance.
- If delisted, company expects securities to trade on OTC Markets platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223018373/0001493152-23-018373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223018373/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-018373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer